ABSI - Absci begins IND-enabling studies for ABS-101 antibody designed using gen AI February, 21 2024 07:46 AM Absci Corporation 2024-02-21 07:46:16 ET More on Absci Absci hits new 52-week high as race for AI drug discovery heats up KeyBanc sees opportunity in tech-enabled drug discovery stocks Seeking Alpha’s Quant Rating on Absci Historical earnings data for Absci Financial information for Absci For further details see: Absci begins IND-enabling studies for ABS-101 antibody designed using gen AI